Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmacological management of migraine: current strategies and future directions
Lanfranco Pellesi, Thien Phu, Anders Hougaard
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 6, pp. 673-683
Open Access | Times Cited: 9

Showing 9 citing articles:

Ubrogepant, erenumab, and eptinezumab antagonize positive inotropic effects of the calcitonin gene–related peptide in the isolated human atrium
Joachim Neumann, Britt Hofmann, Ulrich Gergs
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Open Access
Health Technology Assessment: Evaluation of 8 CGRP-Targeted Therapy Drugs for the Treatment of Migraine
Mengyi Li, Siyong Huang, Jiabao Li, et al.
Drug Design Development and Therapy (2025) Vol. Volume 19, pp. 1231-1247
Open Access
Clinical, Radiological Characteristics and Outcomes of Primary Headache in Children at a Tertiary Hospital in Kenya: A Retrospective Observational Study
Dorcas Tunje, Katherine Oyieke, Pauline Samia
(2025) Vol. 12
Closed Access
Consulting, diagnosis and treatment patterns in migraine: results from the Migraine in Poland cross-sectional survey
Marta Waliszewska‐Prosół, Marcin Straburzyński, Sławomir Budrewićz, et al.
Therapeutic Advances in Neurological Disorders (2025) Vol. 18
Open Access
The influence of pharmacodynamics and pharmacokinetics on the antimigraine efficacy and safety of novel anti-CGRPergic pharmacotherapies: a narrative review
Abimael González‐Hernández, Carlos M. Villalón
Expert Opinion on Drug Metabolism & Toxicology (2024)
Closed Access | Times Cited: 2
Enhancing Acute Migraine Treatment: Exploring Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for the Nose-to-Brain Route
Joana Torres, Renata Silva, Gonçalo Farias, et al.
Pharmaceutics (2024) Vol. 16, Iss. 10, pp. 1297-1297
Open Access | Times Cited: 2
Atogepant for migraine prevention: a meta-analysis of safety and efficacy in adults
Adarsh Raja, Rabia Asim, Muhammad Hamza Shuja, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 1
The prodrome of migraine: mechanistic insights and emerging therapeutic strategies
Liang Gao, Fangling Zhao, Yujie Tu, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access
Role of memantine in adult migraine: a systematic review and network meta-analysis to compare memantine with existing migraine preventive medications
Guanglu Li, Baoquan Qu, Tao Zheng, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
The Impact of Migraine on the Whole Life Course of Patients: Results from the OVERCOME (Japan) 2nd Study
Daisuke Danno, Shiho Suzuki, Tsubasa Takizawa, et al.
Neurology and Therapy (2024)
Open Access
Page 1

Scroll to top